Literature DB >> 18753648

Brain-derived neurotrophic factor and obesity in the WAGR syndrome.

Joan C Han1, Qing-Rong Liu, MaryPat Jones, Rebecca L Levinn, Carolyn M Menzie, Kyra S Jefferson-George, Diane C Adler-Wailes, Ethan L Sanford, Felicitas L Lacbawan, George R Uhl, Owen M Rennert, Jack A Yanovski.   

Abstract

BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been found to be important in energy homeostasis in animal models, but little is known about its role in energy balance in humans. Heterozygous, variably sized, contiguous gene deletions causing haploinsufficiency of the WT1 and PAX6 genes on chromosome 11p13, approximately 4 Mb centromeric to BDNF (11p14.1), result in the Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR) syndrome. Hyperphagia and obesity were observed in a subgroup of patients with the WAGR syndrome. We hypothesized that the subphenotype of obesity in the WAGR syndrome is attributable to deletions that induce haploinsufficiency of BDNF.
METHODS: We studied the relationship between genotype and body-mass index (BMI) in 33 patients with the WAGR syndrome who were recruited through the International WAGR Syndrome Association. The extent of each deletion was determined with the use of oligonucleotide comparative genomic hybridization.
RESULTS: Deletions of chromosome 11p in the patients studied ranged from 1.0 to 26.5 Mb; 58% of the patients had heterozygous BDNF deletions. These patients had significantly higher BMI z scores throughout childhood than did patients with intact BDNF (mean [+/-SD] z score at 8 to 10 years of age, 2.08+/-0.45 in patients with heterozygous BDNF deletions vs. 0.88+/-1.28 in patients without BDNF deletions; P=0.03). By 10 years of age, 100% of the patients with heterozygous BDNF deletions (95% confidence interval [CI], 77 to 100) were obese (BMI > or = 95th percentile for age and sex) as compared with 20% of persons without BDNF deletions (95% CI, 3 to 56; P<0.001). The critical region for childhood-onset obesity in the WAGR syndrome was located within 80 kb of exon 1 of BDNF. Serum BDNF concentrations were approximately 50% lower among the patients with heterozygous BDNF deletions (P=0.001).
CONCLUSIONS: Among persons with the WAGR syndrome, BDNF haploinsufficiency is associated with lower levels of serum BDNF and with childhood-onset obesity; thus, BDNF may be important for energy homeostasis in humans. 2008 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753648      PMCID: PMC2553704          DOI: 10.1056/NEJMoa0801119

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  41 in total

Review 1.  Molecular physiology of syndromic obesities in humans.

Authors:  Wendy K Chung; Rudolph L Leibel
Journal:  Trends Endocrinol Metab       Date:  2005-08       Impact factor: 12.015

2.  Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations.

Authors:  Marta Ribasés; Mònica Gratacòs; Fernando Fernández-Aranda; Laura Bellodi; Claudette Boni; Marija Anderluh; Maria Cristina Cavallini; Elena Cellini; Daniela Di Bella; Stefano Erzegovesi; Christine Foulon; Mojca Gabrovsek; Philip Gorwood; Johannes Hebebrand; Anke Hinney; Jo Holliday; Xun Hu; Andreas Karwautz; Amélie Kipman; Radovan Komel; Benedetta Nacmias; Helmut Remschmidt; Valdo Ricca; Sandro Sorbi; Martina Tomori; Gudrun Wagner; Janet Treasure; David A Collier; Xavier Estivill
Journal:  Eur J Hum Genet       Date:  2005-04       Impact factor: 4.246

3.  WAGR syndrome and multiple exostoses in a patient with del(11)(p11.2p14.2).

Authors:  J M McGaughran; H B Ward; D G Evans
Journal:  J Med Genet       Date:  1995-10       Impact factor: 6.318

4.  The impact of age, weight and gender on BDNF levels in human platelets and plasma.

Authors:  Marek Lommatzsch; Doerte Zingler; Katharina Schuhbaeck; Katharina Schloetcke; Christiana Zingler; Peter Schuff-Werner; Johann Christian Virchow
Journal:  Neurobiol Aging       Date:  2005-01       Impact factor: 4.673

5.  Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion.

Authors:  Dominique Brémond-Gignac; John A Crolla; Henri Copin; Agnès Guichet; Dominique Bonneau; Laurence Taine; Didier Lacombe; Clarisse Baumann; Brigitte Benzacken; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2005-04       Impact factor: 4.246

6.  Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder.

Authors:  S Friedel; F Fontenla Horro; A K Wermter; F Geller; A Dempfle; K Reichwald; J Smidt; G Brönner; K Konrad; B Herpertz-Dahlmann; A Warnke; U Hemminger; M Linder; H Kiefl; H P Goldschmidt; W Siegfried; H Remschmidt; A Hinney; J Hebebrand
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-01-05       Impact factor: 3.568

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Characteristics of BDNF-induced weight loss.

Authors:  M A Pelleymounter; M J Cullen; C L Wellman
Journal:  Exp Neurol       Date:  1995-02       Impact factor: 5.330

9.  Obesity: a new feature of WAGR (del 11p) syndrome.

Authors:  S Marlin; D Couet; D Lacombe; C Cessans; D Bonneau
Journal:  Clin Dysmorphol       Date:  1994-07       Impact factor: 0.816

Review 10.  The genetics of human obesity.

Authors:  Christopher G Bell; Andrew J Walley; Philippe Froguel
Journal:  Nat Rev Genet       Date:  2005-03       Impact factor: 53.242

View more
  122 in total

Review 1.  Childhood obesity.

Authors:  Joan C Han; Debbie A Lawlor; Sue Y S Kimm
Journal:  Lancet       Date:  2010-05-05       Impact factor: 79.321

Review 2.  Genetic approaches to understanding human obesity.

Authors:  Shwetha Ramachandrappa; I Sadaf Farooqi
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

3.  A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques.

Authors:  Francesca Cirulli; Andreas Reif; Sabine Herterich; K Peter Lesch; Alessandra Berry; Nadia Francia; Luigi Aloe; Christina S Barr; Stephen J Suomi; Enrico Alleva
Journal:  Psychoneuroendocrinology       Date:  2010-12-09       Impact factor: 4.905

4.  New insights into the mechanisms underlying the effects of BDNF on eating behavior.

Authors:  Maribel Rios
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

Review 5.  Recent Progress in the Understanding of Obesity: Contributions of Genome-Wide Association Studies.

Authors:  Mette Korre Andersen; Camilla Helene Sandholt
Journal:  Curr Obes Rep       Date:  2015-12

6.  Pediatric obesity. An introduction.

Authors:  Jack A Yanovski
Journal:  Appetite       Date:  2015-03-30       Impact factor: 3.868

7.  Alpha2delta-1 in SF1+ Neurons of the Ventromedial Hypothalamus Is an Essential Regulator of Glucose and Lipid Homeostasis.

Authors:  Jennifer A Felsted; Cheng-Hao Chien; Dongqing Wang; Micaella Panessiti; Dominique Ameroso; Andrew Greenberg; Guoping Feng; Dong Kong; Maribel Rios
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  Ablation of TrkB expression in RGS9-2 cells leads to hyperphagic obesity.

Authors:  Guey-Ying Liao; Yuqing Li; Baoji Xu
Journal:  Mol Metab       Date:  2013-08-09       Impact factor: 7.422

Review 9.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

Review 10.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.